Overview In April 2023 Belgium's Special Pharmaceuticals exports accounted up to €116M and imports accounted up to €74.2M, resulting in a positive trade balance of €42.1M. Between April 2022 and April 2023 the exports of Belgium's Special Pharmaceuticals have increased by €45.1M (63.3%) from €71.2M to €116M, while imports increased by €1.8M (2.49%) from €72.4M to €74.2M.
Destinations In April 2023, Special Pharmaceuticals were exported mostly to United States (€21.3M), Germany (€16.5M), Singapore (€10.6M), Italy (€6.36M), and France (€5.94M), and were imported mostly from United States (€30.2M), Germany (€16.5M), Switzerland (€9.6M), Japan (€4.3M), and Brazil (€4.01M).
Growth In April 2023, the increase in Special Pharmaceuticals's year-by-year exports was explained primarily by an increase in exports to United Kingdom (€4.93M or 353%), United States (€2.31M or 15.3%), and Germany (€2.02M or 22.5%). In April 2023, the increase in Special Pharmaceuticals's year-by-year imports was explained primarily by an increase in imports from United States (€8.86M or 64%), Canada (€4.33M or 1.48k%), and Switzerland (€1.43M or 44.8%).